Hypertension fuels osteoarthritis through neuroendocrine signaling.

Hypertension accelerates osteoarthritis progression by activating the AVP-AVPR1A neuroendocrine pathway, with a 2.5-fold increase in cartilage degradation observed in hypertensive models.

• Why it matters: Osteoarthritis worsens with systemic metabolic stress, but the specific mechanisms linking hypertension to joint degeneration remain unclear, hindering targeted therapies.
• What they did: The study combined nationwide cohort data and hypertensive mouse models to investigate how elevated blood pressure influences OA, focusing on chondrocyte responses and signaling pathways.
• The result: Blocking AVPR1A or silencing NR4A3 protected against hypertension-induced cartilage breakdown, revealing potential therapeutic targets to mitigate joint degeneration associated with hypertension.